ImmuneOnco Biopharmaceuticals (Shanghai) Inc. (1541.HK) HKSE

4.53

-0.02(-0.44%)

Updated at February 20 04:08PM

Currency In HKD

Valuation

Market Cap1.83B
Enterprise Value1.49B
P/E Ratio-5.39
PEG Ratio-0.75
Price/Sales Ratio13.71
Price/Book Ratio3.05
Enterprise/Revenue9.23
Enterprise/EBITDA-3.77

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin-2.46
Operating Margin-2.53

Management Effectiveness

Return On Assets-0.39
Return On Equity-0.5

Income Statement

Revenue74.15M
Revenue/Share0.3
Gross Profit74.15M
EBITDA-295.63M
Net Income-315.86M
Diluted EPS-0.84

Balance Sheet

Total Cash703.7M
Total Cash/Share1.73
Total Debt153.72M
Total Debt/Equity0.29
Current Ratio3.33
Book Value Per Share1.31

Price History

52-Week Change-27.87
52-Week High16.8
52-Week Low4.01
Moving Average 50 Days5.63
Moving Average 200 Days9.46

Statistics

Average Volume1.33M
Shares Outstanding420.48M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A